» Articles » PMID: 26001306

ACR Appropriateness Criteria Evaluation of the Symptomatic Male Breast

Overview
Publisher Elsevier
Specialty Radiology
Date 2015 May 24
PMID 26001306
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Most male breast problems are benign, and men with typical symptoms of gynecomastia or pseudogynecomastia do not usually need imaging. When a differentiation between benign disease and breast cancer cannot be made on the basis of clinical findings or when the clinical findings are suspicious for breast cancer, imaging is indicated. Mammography is useful in both identifying cancer and obviating the need for biopsy in patients for whom a benign mammographic impression confirms the clinical impression. However, because of the relationship of breast cancer to increasing age, age-based protocols that do not include mammography have been developed. For men with an indeterminate palpable mass, begin with ultrasound if the patient is <25 years of age, because breast cancer is highly unlikely. Mammography should be performed if ultrasound is suspicious. For men ≥25 years of age or having a highly concerning physical examination, usually begin with mammography; ultrasound is useful if mammography is inconclusive or suspicious. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals, and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Citing Articles

Male and female disparities in breast cancer epidemiology: A comparative cross-sectional analysis of a Brazilian cohort (2017-2021).

Antonini M, Mattar A, Pannain G, Buttenbender S, Pereira da Costa Pinheiro D, Teixeira M Heliyon. 2024; 10(18):e38183.

PMID: 39364238 PMC: 11447307. DOI: 10.1016/j.heliyon.2024.e38183.


Male Breast Cancer: Imaging Considerations for Diagnosis and Surveillance.

Thomas M, Al Kashroom H, Reddy S, Zaccarini D, Willer K J Clin Med Res. 2024; 16(5):197-207.

PMID: 38855781 PMC: 11161189. DOI: 10.14740/jocmr5169.


Demographics, Characteristics, and Outcomes of Male Breast Cancer Patients at the Methodist Health System, Dallas, USA.

Nong H, Eastwood D, Rodriguez K, Puri V Cureus. 2023; 15(11):e49394.

PMID: 38146568 PMC: 10749682. DOI: 10.7759/cureus.49394.


Assessing the impact of a gynaecomastia assessment and treatment infographic in primary care in Greater Manchester.

Bromley H, Preston M, Walter L, Dave R, Lord N, Wright P Ann R Coll Surg Engl. 2021; 104(3):174-180.

PMID: 34822303 PMC: 9773909. DOI: 10.1308/rcsann.2021.0149.


Unusual Male Breast Lesions.

Alsharif S, Alshamrani K, Scaranelo A, Khoumais N, Subahi A, Mesurolle B J Clin Imaging Sci. 2021; 11:21.

PMID: 33948337 PMC: 8088480. DOI: 10.25259/JCIS_43_2021.